Correction: Accessing hepatitis C direct acting antivirals among people living with hepatitis C: a qualitative study

Correction: Accessing hepatitis C direct acting antivirals among people living with hepatitis C: a qualitative study

Bibliographic Details
Main Authors:	Tony Antoniou, Cheryl Pritlove, Dana Shearer, Mina Tadrous, Hemant Shah, Tara Gomes
Format:	Article
Language:	English
Published:	BMC 2023-10-01
Series:	International Journal for Equity in Health
Online Access:	https://doi.org/10.1186/s12939-023-02003-4

Similar Items

Accessing hepatitis C direct acting antivirals among people living with hepatitis C: a qualitative study
by: Tony Antoniou, et al.
Published: (2023-06-01)

Regional differences in access to direct-acting antiviral treatments for hepatitis C across Ontario: A cross-sectional study
by: Natalia Konstantelos, et al.
Published: (2022-04-01)

New treatment of hepatitis C (Direct Acting Antiviral)
by: Mohsen Akhondi-Meybodi
Published: (2019-10-01)

Access to direct-acting antivirals for the treatment of hepatitis C in a country with limited resources
by: S. Marciano, et al.
Published: (2018-04-01)

Characterisation of Hepatitis C Virus antiviral resistance in the era of direct acting antivirals
by: Smith, D
Published: (2019)

Mechanisms of Hepatitis C Viral Resistance to Direct Acting Antivirals
by: Asma Ahmed, et al.
Published: (2015-12-01)

Mexican experience with direct-acting antivirals in the treatment of hepatitis C
by: J.L. Pérez Hernández, et al.
Published: (2020-09-01)

P-34 OUTCOME OF HEPATITIS C TREATMENT WITH DIRECT-ACTING ANTIVIRALS AFTER UNIVERSAL ACCESS TO THERAPY
by: S. Blanco-Sampascual, et al.
Published: (2021-09-01)

The impact of unrestricted access to direct-acting antiviral among incarcerated hepatitis C virus-infected patients
by: Yu Jun Wong, et al.
Published: (2021-07-01)

Risk assessment and management of hepatitis B reactivation from direct-acting antivirals for hepatitis C
by: Maureen Whitsett, et al.
Published: (2019-06-01)

Hepatitis C in healthcare personnel: secondary data analysis of therapies with direct-acting antiviral agents
by: Claudia Westermann, et al.
Published: (2018-05-01)

Hepatitis C in healthcare personnel: follow-up analysis of treatments with direct-acting antiviral agents
by: Claudia Westermann, et al.
Published: (2021-08-01)

Perceived physical health outcomes of direct-acting antiviral treatment for hepatitis C: a qualitative study
by: Stelliana Goutzamanis, et al.
Published: (2021-07-01)

Direct-acting antiviral resistance of Hepatitis C virus is promoted by epistasis
by: Hang Zhang, et al.
Published: (2023-11-01)

Pangenotypic Direct Acting Antivirals Treatment for Chronic Hepatitis C Infection
by: Juferdy Kurniawan
Published: (2020-07-01)

The efficacy of direct-acting antiviral therapy in patients with chronic hepatitis C
by: Irina RUSU, et al.
Published: (2020-03-01)

Incidence of depression in patients with hepatitis C treated with direct-acting antivirals
by: Elfi Egmond, et al.

Bioequivalent pharmacokinetics for generic and originator hepatitis C direct-acting antivirals
by: Andrew Hill, et al.
Published: (2018-04-01)

The Direct-Acting Antivirals for Hepatitis C Virus and the Risk for Hepatocellular Carcinoma
by: Paulina Chinchilla-López, et al.
Published: (2017-05-01)

Hepatitis C virus, directly acting antivirals and Guillain-Barré syndrome
by: Manish Balwani, et al.
Published: (2018-01-01)

Effects of Age on Treatment of Chronic Hepatitis C with Direct Acting Antivirals
by: Alexandre Pariente, et al.
Published: (2019-01-01)

Clinical utility of hepatitis C virus core antigen assay in the monitoring of direct-acting antivirals for chronic hepatitis C.
by: Sheng Feng Lin, et al.
Published: (2020-01-01)

Regression in hepatic fibrosis in elderly Chinese patients with hepatitis C receiving direct-acting antiviral treatment
by: Bin Niu, et al.
Published: (2023-04-01)

Outcome of direct-acting antiviral treatment in patients with hepatitis C virus/hepatitis B virus coinfection
by: El-Araby Mohamed Ibrahim Shalaby, et al.
Published: (2023-06-01)

Direct‐Acting Antiviral Treatment of Patients with Hepatitis C Resolves Serologic and Histopathologic Features of Autoimmune Hepatitis
by: Camila C. Simoes, et al.
Published: (2019-08-01)

Hepatic fibrosis changes in patients with chronic hepatitis C infection who respond to direct-acting antivirals
by: Khalid Alswat, et al.
Published: (2022-03-01)

Towards supporting greater and lower cost access to direct acting antiviral treatment for hepatitis C for all patients
by: Said A Al-Busafi, et al.
Published: (2017-01-01)

Access to hepatitis C medicines
by: Danny J Edwards, et al.
Published: (2015-11-01)

Metabolic and renal changes in patients with chronic hepatitis C infection after hepatitis C virus clearance by direct‐acting antivirals
by: Riccardo Nevola, et al.
Published: (2020-08-01)

Hepatitis C Clearance by Direct-Acting Antivirals Impacts Glucose and Lipid Homeostasis
by: Christiana Graf, et al.
Published: (2020-08-01)

Outcomes and Follow-Up after Hepatitis C Eradication with Direct-Acting Antivirals
by: Erica Nicola Lynch, et al.
Published: (2023-03-01)

Cardiovascular Risk in Patients with Chronic Hepatitis C Treated with Direct Acting Antivirals
by: Mohammad Said Ramadan, et al.
Published: (2022-09-01)

Quality and Efficacy Concerns with Generics in Treatment of Hepatitis C with Directly Acting Antivirals
by: Bader Faiyaz Zuberi
Published: (2017-08-01)

Quality and Efficacy Concerns with Generics in Treatment of Hepatitis C with Directly Acting Antivirals
by: Bader Faiyaz Zuberi
Published: (2017-08-01)

Impact of hepatitis C virus eradication with direct-acting antivirals on glycidic metabolism
by: Jucéli Márcia Hendges Sparvoli, et al.
Published: (2023-01-01)

Hepatitis C Direct Acting Antivirals and Ribavirin Modify Lipid but not Glucose Parameters
by: Mary-Anne Doyle, et al.
Published: (2019-03-01)

Monitoring the treatment of hepatitis C with directly acting antivirals by serological and molecular methods.
by: Elisabetta Loggi, et al.
Published: (2017-01-01)

Effectiveness of direct-acting antivirals in Hepatitis C virus infection in haemodialysis patients
by: Soraya Abad, et al.
Published: (2017-03-01)

Reactivation of herpesvirus in patients with hepatitis C treated with direct-acting antiviral agents
by: Ghweil AA, et al.
Published: (2019-04-01)

Unmet needs of chronic hepatitis C in the era of direct-acting antiviral therapy
by: Chung-Feng Huang, et al.
Published: (2020-07-01)